MENU
GPCR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Structure Therapeutics (GPCR) Ownership - Who owns Structure Therapeutics?
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more
Profile
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 457-1978
Employees
93
Web
https://www.structuretx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.36B
P/E Ratio
N/A
Total Cash
883.52M
Projected Growth
N/A
Total Debt
3.86M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
15.41
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GPCR
Capitalization
1.36B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
884M
Total Cash/Share
15.41
Total Debt
3.86M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
865M
P/B Ratio
1.57
Cash Flow
N/A
Earnings
-2.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17K
Current Ratio
24.74
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-157.24M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-17.69
Shares Held By Institutions
7.53B
Shares Outstanding - Current
57.3M
Total Liabilities
38.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-12.795
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 457-1978
Employees
93
Web
https://www.structuretx.com